Clinical outcomes from randomisation to follow-up
| CTO-PCI (n=148) | CTO-No PCI (n=154) | P value | |
| MACE at 4-month follow-up | |||
| Composite of cardiac death/MI/CABG surgery surgery | 8 (5∙4%) | 4 (2∙6%) | 0∙25 |
| Cardiac death | 4 (2∙7%) | 0 – | 0∙06 |
| MI | 5 (3∙4%) | 3 (1∙9%) | 0∙49 |
| Periprocedural | 4 | 1 | – |
| CABG surgery | – | 1 (0∙6%) | – |
| MACE at 1-year follow-up | |||
| Composite of cardiac death/MI/CABG surgery surgery | 11 (7∙4%) | 10 (6∙5%) | 0∙82 |
| Cardiac death | 4 (2∙7%) | 0 – | 0∙06 |
| MI | 8 (5∙8%) | 9 (5∙8%) | 0∙79 |
| Periprocedural | 4 | 2 | – |
| CABG surgery | 3 (2∙0%) | 1 (0∙6%) | 0∙36 |